Active Biotech AB (publ) (LON: 0GQU)

Active Biotech AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	-	-	-	-	6.73	8.43
Revenue Growth (YoY)	-	-	-	-	-20.18%	-57.98%
Gross Profit	-	-	-	-	6.73	8.43
Selling, General & Admin	13.14	13.94	15.06	15.25	13.48	12.24
Research & Development	29.24	32.54	42.82	34.54	25.55	28.47
Operating Expenses	42.38	46.48	57.89	49.78	39.03	40.71
Operating Income	-42.38	-46.48	-57.89	-49.78	-32.31	-32.29
Interest Expense	-0.24	-0.24	-0.21	-0.03	-0.09	-1.94
Interest & Investment Income	0.29	0.29	0.05	-	-	-
Currency Exchange Gain (Loss)	0.07	0.07	-0.01	0.02	-0.07	0.09
EBT Excluding Unusual Items	-42.17	-46.37	-58.05	-49.79	-32.46	-34.13
Gain (Loss) on Sale of Investments	0.57	0.57	-0.32	-0.03	0.22	0
Pretax Income	-41.6	-45.8	-58.37	-49.83	-32.25	-34.13
Net Income	-41.6	-45.8	-58.37	-49.83	-32.25	-34.13
Net Income to Common	-41.6	-45.8	-58.37	-49.83	-32.25	-34.13
Shares Outstanding (Basic)	344	272	234	214	169	145
Shares Outstanding (Diluted)	344	272	234	214	169	145
Shares Change (YoY)	29.63%	16.21%	9.23%	26.87%	16.09%	5.63%
EPS (Basic)	-0.12	-0.17	-0.25	-0.23	-0.19	-0.24
EPS (Diluted)	-0.12	-0.17	-0.25	-0.23	-0.19	-0.24
Free Cash Flow	-39.54	-45.74	-54.85	-46.17	-32.22	-35.81
Free Cash Flow Per Share	-0.11	-0.17	-0.23	-0.22	-0.19	-0.25
Gross Margin	-	-	-	-	100.00%	100.00%
Operating Margin	-	-	-	-	-480.39%	-383.20%
Profit Margin	-	-	-	-	-479.48%	-405.13%
Free Cash Flow Margin	-	-	-	-	-479.05%	-425.08%
EBITDA	-40.78	-44.78	-57.89	-48.48	-31.01	-32.19
D&A For EBITDA	1.6	1.7	0	1.3	1.3	0.1
EBIT	-42.38	-46.48	-57.89	-49.78	-32.31	-32.29

Source: S&P Capital IQ. Standard template. Financial Sources.